Higher systemic AL amyloidosis scores at diagnosis predict development of new-onset atrial fibrillation or flutter
Clicks: 1
ID: 323386
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #232 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Light chain cardiac amyloidosis (AL-CM) is an infiltrative cardiomyopathy associated with significant morbidity and mortality. Early diagnosis and risk stratification is critical for prognostication and management, particularly identifying patients most likely to need heart transplants. The systemic light chain amyloidosis (sAL) score is derived from echocardiographic parameters: relative wall thickness (RWT), E/e' ratio, global longitudinal strain (GLS), and tricuspid annular plane systolic excursion (TAPSE) and is validated in the diagnosis of AL-CM [1]. Its prognostic value for development of atrial fibrillation, progression of heart failure, and hospitalizations remains unclear. This study evaluates the association between the sAL score, arrhythmias, and functional outcomes in patients with confirmed AL-CM. Methods A retrospective review of patients seen at our hospital, with confirmed AL-CM diagnosed between June 2014 and October 2021 was conducted on an IRB-approved protocol. The sAL score was collected at the time of diagnosis. Binary outcomes were evaluated using a weighted Mann-Whitney U test, with effect size calculated as r=Z/sqrt(N). Ordinal and continuous outcomes were analysed using weighted Spearman correlation, with Spearman’s rho reported as the effect size. Results 37 patients with AL-CM were included (51.4% male), with a median age of 70 years [IQR 66–76], a median sAL score of 5 [IQR 3–6], and a median left ventricular ejection fraction (LVEF) of 55% [IQR 50–60] at diagnosis. 24 patients had their AL-CM diagnosed by cardiac MRI and positive Congo red on peripheral biopsy (e.g., fat pad); the other 13 had positive endomyocardial biopsy. 22 patients had sAL scores ≥ 5 with overall survival of 17/22 (77.3%) and median follow-up of 53 months. 15 patients had sAL scores < 5 with overall survival of 14/15 (93.3%) and median follow-up of 57 months. 4 patients had atrial fibrillation or flutter at diagnosis. 6 patients developed atrial fibrillation or flutter with a median onset of 15 months after diagnosis. Higher sAL scores at diagnosis were associated with development of new-onset atrial fibrillation or flutter (median sAL 4.5 vs 5, p = 5.75×10^-10, r = 1.02), heart failure hospitalizations (median sAL 5 vs 5, p = 1.94×10^-6, r = 0.78), and ≥30% eGFR decline at 12 months (median sAL 4.5 vs 6, p=8.69×10^-24, r = 1.65). Higher sAL scores were moderately correlated with NYHA class (rho = 0.44, p = 0.00378) and strongly correlated with diastolic dysfunction grade (rho = 0.549, p = 9.99×10^-6) but not associated with change in LVEF (p = 0.51 and p = 0.62, respectively). Conclusion sAL scores of ≥5 at diagnosis were associated with worse functional and clinical outcomes in patients with proven AL-CM. These findings suggest the sAL score predicts electrophysiological changes, supporting its potential role in early risk stratification and disease monitoring.
| Reference Key |
openalex_W7172325339
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | J Di Palma-Grisi, S Hazaveh, Y Weiss, J Yu, M Vandyck-Acquah, H Parmar |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag097.057
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.